Sunshine Biopharma Cash from Investing (TTM) Analysis

Sunshine Biopharma Inc (SBFM)

3.32 -0.48 (-12.63%) USD | NASDAQ | Apr 18, 16:00

3.29 -0.03 (-0.90%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2011. Upgrade now.

Date	Value
December 31, 2023	-0.6562M
September 30, 2023	-15.01M
June 30, 2023	-15.03M
March 31, 2023	-14.77M
December 31, 2022	-14.62M
September 30, 2022
June 30, 2022
March 31, 2022
December 31, 2021
September 30, 2021
June 30, 2021
March 31, 2021
December 31, 2020
September 30, 2020
June 30, 2020
March 31, 2020	-0.0153M
December 31, 2019
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018	-0.0139M
September 30, 2018	-0.1064M
June 30, 2018	-0.1644M
March 31, 2018	-0.1641M
December 31, 2017	-0.084M

Date	Value
September 30, 2017	-0.0011M
June 30, 2017	-0.0234M
March 31, 2017	-0.0034M
December 31, 2016	-0.0034M
September 30, 2016	-0.6256M
June 30, 2016	-0.6256M
March 31, 2016	-0.6233M
December 31, 2015	-0.6233M
September 30, 2015	0.00
June 30, 2015	0.00
March 31, 2015	0.00
December 31, 2014	0.00
September 30, 2014	0.00
June 30, 2014	0.00
March 31, 2014	0.00
December 31, 2013	0.00
September 30, 2013	0.00
June 30, 2013	0.00
March 31, 2013	0.00
December 31, 2012	0.00
September 30, 2012	0.00
June 30, 2012	0.00
March 31, 2012	0.00
December 31, 2011	0.00
September 30, 2011	0.00

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-15.03M

Minimum

Jun 2023

-0.0153M

Maximum

Mar 2020

-10.01M

Average

-14.69M

Median

Cash from Investing (TTM) Benchmarks